March 2021

26 Mar

Posted at 14:30h in Patients/Healthcare Providers, Update by
1 Like

All TreatGx users now have access to the updated treatment algorithms for Depression, Heart Failure - Fluid Retention, Chronic Pain - Trigeminal Neuralgia, and Hyperlipidemia.  Depression  In light of its recent approval in Canada and the US, esketamine nasal spray (Spravato) has been added to the Depression Augmentation/Adjunctive therapy options. Highlights include:  Approved by Health Canada for adjunctive use with an SSRI or...

03 Mar

Posted at 14:07h in Patients/Healthcare Providers, Update by
1 Like

All TreatGx users now have access to the updated treatment algorithms for Atrial Fibrillation – Anticoagulation and Anxiety – Social Anxiety Disorder. Atrial Fibrillation – Anticoagulation The updated atrial fibrillation anticoagulation algorithm provides a streamlined approach to medication options when initiating or switching between anticoagulants. Switching instructions have been updated...